Patents Expiring in February 2037
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ENTRESTO SPRINKLE | sacubitril; valsartan | CAPSULE, PELLETS;ORAL | 218591-001 | Apr 12, 2024 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | Y | TREATMENT OF HEART FAILURE WITH ORAL PELLETS | |||
| Novartis | ENTRESTO SPRINKLE | sacubitril; valsartan | CAPSULE, PELLETS;ORAL | 218591-002 | Apr 12, 2024 | RX | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | Y | TREATMENT OF HEART FAILURE WITH ORAL PELLETS | |||
| Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-001 | Jun 23, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ||||
| Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-001 | Jun 23, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | Y | TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | |||
| Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-001 | Jun 23, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | Y | TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | |||
| Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-001 | Jun 23, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ||||
| Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-001 | Jun 23, 2022 | RX | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
